ReviewCancers2025
Delay in Diagnosis and Treatment of Bone Sarcoma-Systematic Review.
Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Patients' experiences of the path to sarcoma diagnosis: a qualitative systematic review and thematic synthesis.BMJ open · 2026Pooled it
- Article
- Diagnostic Intervals in Children, Adolescents and Young Adults with Primary Bone Sarcoma: A Systematic Review.Cancers · 2026Review
- How Much Do Healthcare Practitioners Know About Sarcoma?Current oncology (Toronto, Ont.) · 2026Article
- Association of Cartilage Cap Thickness With Tumor Grade and Outcomes in Secondary Chondrosarcoma.The Journal of the American Academy of Orthopaedic Surgeons · 2026Article
- Primary osseous malignancies of the foot: a comprehensive literature review and insights from a single-centre experience.Journal of bone oncology · 2026Review
- Article
- SHIELD: An AI Framework for Skeletal Health Intelligence and Early Lesion Detection to Improve Orthopedic Referrals.Journal of medical systems · 2026Article
- Article
- Diagnostic familiarity with osteochondroma among primary physicians: a retrospective analysis of 195 referred cases.Archives of orthopaedic and trauma surgery · 2026Article
- Risk Factors, Clinical Manifestations, and Treatment Outcomes of Primary Bone Sarcomas.Saudi medical journal · 2026Article
- Actionable diagnostic delay in primary malignant bone tumors: a trigger-to-action framework for first-contact clinicians.Frontiers in oncology · 2026Review
- How Musculoskeletal Tumor Management Changed During the COVID-19 Pandemic: Data from a Nationwide Questionnaire Survey of Hospitals Specializing in Musculoskeletal Tumors in Japan.Current oncology (Toronto, Ont.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Delay in the diagnosis and treatment of rare types of cancers such as bone sarcoma still remains an important problem [...].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.